Foundations such as Deutsche Krebshilfe (German Cancer Aid) or the Volkswagen Foundation make a significant contribution to the promotion of our programs and projects. Our currently funded and recently completed projects with a funding amount of over 200,000 EUR are listed below:
Deutsche Krebshilfe
AML-CARE – Identification of somatic and psychosocial late effects and risk factors in AML long-term survivors as a basis for evidence-based follow-up care
Project Manager: Prof. Dr. Klaus Metzeler
Project Duration: 2025 - 2028
Hector-Stiftung
ISOLA – Identifying the optimal Sequence for bispecific antibodies and CAR T cells in multiple myeloma through single cell multi-omics
Project Manager: Prof. Maximilian Merz / Dr. Kristin Reiche
Project Duration: 2026 – 2030
José Carreras Stiftung
Decoding extramedullary myeloma disease using spatially resolved single sequencing
Project Manager: Prof. Maximilian Merz / Dr. Kristin Reiche
Project Duration: 2023 – 2025
Interference in TCL1A-mediated signaling pathways of T-cell lymphocytic leukemias
Project Manager: Prof. Dr. Achim Aigner / Prof. Dr. Marco Herling
Project Duration: 2024 – 2027
Volkswagen Stiftung
Innovative Approaches to Antiviral Drug Development – Peptide-based crystallographic fragment screening for fast and efficient discovery of lead structures against zoonotic viral diseases
Project Participants: Prof. Jens Meiler, Prof. Norbert Sträter, Prof. Ralf Hoffmann
Project Duration: 2021 – 2024
LEARN MORE